QUEEN'S BENCH DIVISION
COMMERCIAL COURT
Strand, London, WC2A 2LL |
||
B e f o r e :
____________________
Gul Bottlers (PVT) Limited |
Claimant |
|
- and - |
||
Nichols Plc |
Defendant |
____________________
Mr Andrew George (instructed by DLA Piper UK LLP) for the Defendant
Hearing dates: 4th, 5th, 6th, 9th, 10th, 11th, 18th, 25th June 2014
____________________
Crown Copyright ©
Mr Justice Cooke:
Introduction
i) Nichols contended that the Agreement had never been for DS Cordial at all but only covered single strength cordial (SS) and carbonated products.ii) Nichols contended that Gul failed to mitigate its losses by rejecting an offer made by Nichols in January 2013 (six months after Gul's letter before action). The offer made was to conclude a new Licence Agreement on the terms which Gul had always contended were the terms of the original Agreement.
iii) Nichols contested the quantum of Gul's loss as put forward by Gul and Mr Sequeira of Navigant Consulting, the expert engaged by Gul. He produced a discounted cash flow analysis, using the "Navigant model" which projected the revenues that Gul would have generated from the sale of Vimto products but for Nichols' alleged breach, projected the costs that Gul would have incurred to realise those sales, projected the cash flows that Gul would have thus generated and, after calculating the applicable discount rate, applied it to establish the present value of the future cash flows. Whilst this methodology was not an issue between Mr Sequeira and Mr Wilkinson, the expert engaged by Nichols, Mr Wilkinson made trenchant criticisms of the model and the use made of it by Mr Sequeira but did not give an opinion himself as to the likely level of loss of profits.
"1. The Defendant concedes:
1.1. The claim for rectification (Particulars of Claim, Prayer, paragraph 1).
1.2. That on 23 July 2012 Gul accepted Nichols repudiatory breaches of the Agreement (Particulars of Claim, paragraph 33).
2. The Defendant does not contend that:
2.1 The Agreement was affirmed (Defence, paragraph 45).
2.2. The refusal of the "marketing rebate" offer constituted a failure to mitigate (Defence, paragraph 51).
3. The Defendant maintains:
3.1 That the refusal of the offer of 24 January 2013 was an unreasonable failure to mitigate (Defence, paragraph 50).
3.2 All quantum arguments, including those relating to whether the Agreement should be treated for the purposes of quantum calculations as subsisting for a 5 or 10-year period."
"When we signed our agreement, our entire strategy was devised according to the prices we were purchasing the concentrate from you. If you look at the pricing schedule (£7 per litre) and compare it to the price you have revised (£26 per litre) it leaves us completely clueless as to what is happening on your end.
Please note that the board is not taking kindly to your continuously changing position and the changes proposed are not acceptable. You need to tell us clearly whether you wish to continue with our partnership on the agreed terms."
The Agreement
"(C) The Licensee wishes to manufacture, package, distribute and sell the Products and, for such purpose, has requested the Licensor to grant a licence of the Trade Marks in respect of the Products and to render related technical assistance subject to and upon the terms and conditions herein set forth.
…
2. RIGHTS GRANTED AND TERRITORY
2.1 The Licensor grants to the Licensee, on the terms set out in this Agreement, an exclusive licence to use the Trade Marks in the Territory or in relation to the Products. The licence is personal to the Licensee and the grant does not include any right to grant sub-licenses or for the Licensee to have the Products manufactured for it by any third party.
3. DURATION
3.1 This Agreement shall commence on the Commencement Date and shall unless terminated in any of the circumstances of Clause 10 of this Agreement continue in force for a period of 5 years.
3.2 The Licensee shall have the option to renew this Agreement:
3.2.1. for a further term of five (5) years commencing immediately upon the expiration of the term hereof;
3.2.2. upon the same terms and conditions hereunder save for this option to renew;
3.2.3 upon giving prior written notice to the Licensor such notice to be given not less than twelve (12) months before the expiration of the term hereof; and
3.2.4 if the Licensee shall have performed and observed all of the terms and conditions herein contained and on its part to be performed and observed up to the expiration of the term hereof,
and if the Licensee shall not have exercised its option to renew as aforesaid then this Agreement shall forthwith terminate at the expiration of the term hereof.
…
7 QUALITY OF PRODUCTS
7.1 All products manufactured by the Licensee under or by reference to the Trade Marks shall comply with the specifications and standards of quality in relation to their manufacture, materials used, workmanship and design, packaging and storage set by the Licensor from time to time.
7.2 For the purpose of ensuring that the Licensee is complying with the Licensor's specifications and standards:
7.2.1 the Licensee shall as requested by the Licensor every three (3) months supply to the Licensor the Licensee's expense samples of the Products for the purpose of inspecting and testing the same;
7.2.2 the Licensor by its authorised representative may on reasonable notice and at its own expense visit the Licensee's premises during normal business hours to inspect the method of manufacture of the Products, the materials used, and the packaging and storage of the Products.
7.3 Products intended to be marketed under the Trade Marks which in the Licensor's opinion are not of the quality required by the Licensor under Clause 7.1 above shall on notice being given by the Licensor be forthwith withdrawn from production and sale by the Licensee and they shall at the Licensor's option either be corrected or destroyed or the Trade Marks removed from them. The Licensor may inspect any such corrected products before they are marketed.
8 RESPECTIVE DUTIES OF THE LICENSOR AND THE LICENSEE
8.1 Subject to and upon the terms and conditions set forth in this Agreement, the Licensor agrees to make available to the Licensee the Know-how and technical support for the purpose of production of the Products at the facilities of the Licensee.
8.2 The Licensor shall advise and make available to the Licensee the Know-how in relation to:
8.2.1 product information, formulations, ingredient, functions and usage factors;
8.2.2 specifications for the Products, including data techniques and procedures for quality control, packaging, handling and storage;
8.2.3 assistance in sales promotion, advertisements and other promotional literature and materials.
8.2.4 any other data and information as the Licensor and the Licensee may deem useful and/or necessary for the purpose of the manufacturing and marketing of the Products.
8.3 The Licensee shall diligently carry on the business of manufacture and distribution of the Products in the Territory and use best endeavours to promote and market the Products in the Territory and to co-operate with the Licensor in this regard and in the development and maintenance of appropriate programmes and procedures for such promotion and marketing.
8.3.1 The Licensee shall reserve a sum of not less than 5% of net sales (ex works price, excluding taxes) of each case for use in marketing the Products in the Territory, and shall provide proof of such expenditure on request.
8.3.2. The Licensee shall provide accurate sales information, in a format reasonably required by the Licensor, such information to be received by the Licensor within five (5) working days of the end of each month.
…
9. PURCHASE OF CONCENTRATE
9.1 During the term of this Agreement, the Licensee shall purchase such quantities of the Concentrate as may be ordered by the Licensee in accordance with the terms of this Agreement.
9.2 The Licensee shall hold a minimum stock of Concentrate sufficient to produce not less than three (3) months of the finished product, based on the previous three (3) months sales.
9.3 Notwithstanding anything to the contrary herein, the Licensee shall purchase from the Licensor the minimum quantities of the Concentrate as follows:
Year of the term of this Agreement | Minimum Quantities |
Year 1 | 2,000 litres |
Year 2 | 3,000 litres |
Year 3 | 5,000 litres |
Year 4 | 8,000 litres |
Year 5 | 10,000 litres |
and thereafter, not less than 10,000 litres in a year. The provision of this Clause 9.3 is fundamental to the Agreement and failure by the Licensee to purchase such minimum quantities shall entitle the Licensor to terminate this Agreement in accordance with Clause 10.
9.4 Each month, the Licensee shall provide accurate details of the opening and closing stocks of Concentrate at their premises, along with consumption figures. This information must be received by the Licensor within five (5) working days of the end of each month.
9.5 No Purchase Order submitted by the Licensee shall be deemed to be accepted by the Licensor unless and until confirmed in writing by the Licensor's authorised representative.
9.6 The Licensor shall use all reasonable endeavours to deliver each of the Licensee's orders for the Concentrate at the port of shipment on an ex works basis on the date specified in the applicable Purchase Order, but the time of delivery shall not be of the essence and if, despite those endeavours, the Licensor is unable for any reason to fulfil any delivery of the Concentrate on the specified date, the Licensor shall not be deemed to be in breach of this Agreement or under any Purchase Order or have any liability to the Licensee. For the sake of clarity, this refers to delivery on a specific date, rather than failure to deliver altogether. Failure to deliver by the specified date may, however, mitigate a proportionate shortfall in annual concentrate requirements.
9.7. All sales of the Concentrate pursuant to this Agreement shall be subject to the standard terms and conditions of sale of the Licensor as amended from time to time, expect to the extent that:
9.8.1 [sic] any provision of those terms and conditions of sale is inconsistent with any provision of this Agreement, in which event the latter shall prevail; or
9.8.2 [sic] the Licensor and the Licensee agree in writing to vary those terms and conditions of sale.
9.8 The Licensee shall only use the Concentrate sold to it by the Licensor in the normal course of manufacturing of the Products and, without prejudice to the generality of the preceding words, not resell any of the Concentrate.
9.9 The price of the Concentrate shall be as set out in Schedule 3.
9.10 The Licensor reserves the right, by giving notice to the Licensee at any time before accepting the Purchase Order, to increase the price of the Concentrate. However, such increases shall be limited to increases in raw materials and manufacturing costs, and be duly informed to the Licensee with a minimum notice of three (3) months.
…
11 INDEMNITY
11.1 The Licensee shall be liable for and will indemnify the Licensor (together with its officers, servants and agents) against any and all liability, loss, damages, costs, legal costs, professional and other expense of any nature whatsoever incurred or suffered by the Licensor whether direct or consequential (including but without limitation any economic loss or other loss of profits, business or goodwill) arising out of any dispute or contractual tortuous [sic] or other claims or proceedings brought against the Licensor by a third party claiming relief against the Licensor by reason of the manufacture, use or sale of any Products by the Licensee or the use of the Licensee of the Trade Marks, except insofar as any such claims may arise from:
11.1.1. any breach of this Agreement by the Licensor;
11.1.2 any invalidity or defect in the title of the Licensor to the Trade Marks not caused by any act or default of the Licensee; or
11.1.3 from the instructions given to the Licensee by the Licensor provided such instructions have been properly carried out by the Licensee.
11.1.4 defects in the Concentrate as supplied by the Licensor, provided that the Concentrate has been diligently inspected by the Licensee before use."
Mitigation – the letter of 16th January 2013
"We refer to your letter dated 15 October 2012.
We consider your client's position to be incorrect as explained in our previous correspondence. Nevertheless, should your client be intent on pursuing litigation, our client wishes to avoid, if at all possible, the significant time and cost that will be expended in dealing with the issues raised by our client's claim. The determination of that claim will involve not only arguments as to the facts and the construction of the Agreement, but also a potentially costly and complex argument regarding the quantum of your client's claim for loss of profits (that it asserts will be suffered for a period spanning 10 years) and which will require significant factual and expert evidence from both parties. Our client is fully prepared to engage with your client in litigation and will vigorously defend its position and pursue its counterclaim if your client chooses to proceed with its threatened course of action. However, solely in the interests of avoiding the cost and time of proceedings, our client is prepared to make an open offer at this stage which it believes will satisfy your client's complaint and which represents a significant concession on its part.
Your client's position is that the Trademark Licence and Support Agreement dated 28 September 2011 (Agreement) should be construed as an agreement for the licence of (amongst other products) double strength Vimto cordial and that the price of the concentrate required to produce that double strength cordial should be as set out in Schedule 3 to the Agreement. Our client is prepared to agree to trade with your client on this basis and to enter into a new agreement on the same terms as the Agreement save for the following matters.
1. double strength Vimto cordial, to be sold in glass bottles (the design and specification of which are to be subject to the terms as stated in the Agreement) shall be added to the list of Products at Schedule 2;
2. this new agreement would be for an extended term to reflect the period during which our respective clients have been in dispute (unless your client would prefer the new agreement to be co-terminous with the current Agreement which our client is also prepared to agree to); and
3. the other terms of the new agreement would be as per the Agreement.
Our client would in these circumstances be prepared to sell concentrate to your client at the prices referred to in schedule 3 to the Agreement, for the purpose of your client producing double strength cordial. This would of course fully mitigate all losses that your client alleges it will suffer as a consequence of the allegations raised in your correspondence.
If your client chooses to reject this offer then we will of course refer to this letter in the course of any proceedings that are subsequently issued by your client and, in particular, by reference to your client's duty to mitigate its losses.
It remains our position that your client's claim is lacking in merit for the reasons previously stated. This proposal is solely a reflection of our client's view that such matters should be capable of a commercial resolution and a wish to focus on on-going business including, it hopes, the development of its brand by your client in Pakistan on the terms outlined above.
This proposal is of course subject to agreement of a new Trademark Licence Support Agreement to reflect the abovementioned changes to the commercial terms.
We look forward to hearing from you.
…"
"We refer to your letter dated 16 January 2013.
Our client's case is that Nichols committed a repudiatory breach of the Trademark Licence and Support Agreement (the "Agreement") when it told our client that it would no longer be permitted to produce the double strength cordial product and a further repudiatory breach of contract when it purported unilaterally to change the price of the Concentrate from that stipulated in the Agreement. The evidence of these fundamental breaches of the Agreement is clear. However, nowhere in your letter does your client accept that it is in breach of its obligations. Instead, we are told that Nichols "is fully prepared to engage with [Gul] in litigation and will vigorously defend its position". We are also told that the offer is made "solely in the interests of avoiding the cost and time of proceedings".
Performance of a new Agreement in the sense your client proposes would require an on-going relationship and regular dealings between our respective clients over a ten year period. In particular, Gul would need to work closely with Nichols to develop the market in Pakistan. Our client has also shown the investment that it made in the Agreement and its commitment to making the relationship a success. In contrast, Nichols has shown complete disregard for Gul's contractual rights. It has also evidenced a wish to prefer the interests of Aujuan [sic] Industries over the interests of our client which is of great concern to our client. Nothing in your client's proposal addresses that.
Given the complete breakdown of trust caused by Nichols' actions and Nichols' failure to acknowledge its breach, our client has no confidence in a continuing relationship with Nichols and regards this belated offer as a legal stratagem and not a bona fide proposal. Consequently, it is rejected.
Yours faithfully
…"
The duration of the contract
i) In breach of clause 4.5, it is said that Gul had not submitted any specimens of the containers, packaging, labels or finishing for carbonated Vimto to Nichols.ii) In breach of clause 8.3 it is said that Gul had failed diligently to carry on the business of manufacture and distribution of carbonated Vimto and that it had never been produced by Gul in quantities sufficient to market the product to the general public.
iii) In breach of clauses 8.3.2 and 9.4 it is said that Gul had failed to provide any information to Nichols regarding sales, the stocks of concentrate or consumption figures.
"The judge conducting the assessment must assume that the defendant would not have acted outside the terms of the contract and would have performed it in his own interest having regard to the relevant factors prevailing at the time. But the court is not required to make assumptions the defaulting party would have acted uncommercially merely in order to spite the claimant. To that extent the parties are to be assumed to have acted in good faith although with their own commercial interests very much in mind."
The economic situation in Pakistan
The soft drinks market in Pakistan
The opportunities for Vimto DS Cordial and Carbonates in Pakistan
i) Liquid concentrates, such as Rooh Afzah and Jam-E-Shirin are regarded as healthier and cheaper alternatives to carbonates or packaged fruit/vegetable juice. This perception was one of the major reasons for vast numbers of Pakistani people switching to concentrates towards the end of the period 2007-2012.ii) The ease of storage of concentrates, as compared with carbonates also assists because refrigeration is not required.
iii) The 4% off-trade volume growth recorded in 2012 is less than the compound annual growth rate of 7% recorded over the period 2007-2012. This was due to high levels of financial pressure faced by Pakistani consumers resulting from rising prices and lack of innovation in the category. Consumers were not offered any new choice in concentrates which could potentially revive their interest in the category.
iv) Powder concentrates recorded faster growth in 2012 than liquid concentrates due to the rising demand for products offering convenience and value, making powder concentrates more popular than liquid concentrates. A wider range of flavours was available in powder concentrates than in liquid concentrates which represented a stark comparison with the leading brands in the latter where Rooh Afza had always been and was likely to remain available in one flavour only.
v) The concentrates category as a whole was becoming more price competitive. The 5% unit price growth in 2012 was due to increases in taxes and rising inflation only.
vi) Liquid concentrates, especially the leading brands were widely regarded as rather old-fashioned and lacking innovation. There had been no change in decades. This had resulted in slow off-trade volume growth with liquid concentrates as compared with powder concentrates.
vii) Retail distribution was relatively wide because of the absence of the need for refrigeration.
viii) Concentrates were consumed by people from all income groups and social classes in Pakistan.
ix) Rooh Afza was a well-established brand in liquid concentrates and it and its manufacturer were regarded as home-grown successes which had become household names by offering relatively healthy soft drinks. Purchasers of Rooh Afza and Jam-E-Shirin registered the highest increase in value sales in concentrates in Pakistan during 2012 because their loyal customers were more than willing to pay more to purchase those brands with recent price hikes.
x) Domestic concentrates, brands and manufacturers completely dominated the market in liquid concentrates whilst international brands and manufacturers played a major role in powder concentrates only.
xi) So far as future prospects were concerned, the concentrates market in Pakistan was expected to continue recording positive growth over the period until 2018 despite the fact that it was a category in which there was little by way of product innovation. That and the inherent instability of the Pakistani economy, rising production costs and the increasing focus on reducing costs and maximising profitability remained the major reason for the stasis in new product developments in the category. That trend was expected to remain in effect until 2018 and was likely to present a challenge in maintaining consumer interest in concentrates over the longer term.
xii) Powder concentrates were expected to fare slightly better over the course of the ensuing years in terms of growth, rising from a smaller sales base than liquid concentrates.
xiii) Price discounts offered for bulk purchases of liquid concentrates in leading supermarkets and hypermarkets in Pakistan were set to remain in effect during the forecast period, especially for products purchased by the dozen.
Gul's business plan
The court's approach to quantification of damage
"… it is fair to resolve uncertainties about what would have happened but for the defendant's wrongdoing by making reasonable assumptions which err, if anything, on the side of generosity to the claimant where it is the defendant's wrongdoing which has created those uncertainties."
Gul's expertise
The grey market
"Have you sold DS Vimto syrup before?
When was the last time you sold DS Vimto syrup?
Thinking about the DS Vimto syrup that you sold last time, what was the SKU size, your purchase price (i.e. trade price) and what was the retail price (i.e. consumer price)?
Approximately how many DS Vimto syrup bottles did you sell during the last year?"
The projected sales over the life of the Agreement
Sales of DS Cordial
"Q 2. As mentioned previously, the manufacturer of Pakola, RC Cola and Bubble Up is planning to introduce Double Strength Vimto in Pakistan. Have you sold Double Strength Vimto Syrup before?
Q 3. When was the last time you sold Double Strength Vimto Syrup?
Q 4. Thinking about the Double Strength Vimto Syrup that you sold last time, what was the SKU size, your purchase price (i.e. trade price) & what was the retail price (i.e. consumer price)?
Q 5. Approximately, how many Double Strength Vimto Syrup bottles did you sell during the last 1 year?
Q 10. Thinking of your experience of selling Double Strength Vimto, what were the more frequent problems/difficulties you faced?
Q 11. If Double Strength Vimto Syrup is positioned in the market at a substantially lower price (e.g., retail price of Rs. 250 per 710ml bottle, or a 20-30% reduction to the current price) and you are assured of a reliable supply of Vimto at this lower price:
- how much Double Strength Vimto Syrup would you expect to sell (bottles per year)?
- and do you think its sales will grow in future?
Q 12. Did you sell Double Strength Vimto Syrup through the year or only in Ramadan?
Q 13. What percentage of your sales were in the month of Ramadan?
Q 16. Why have you not sold Double Strength Vimto Syrup?
Q. 17. We understand 710 ml Double Strength Vimto Syrup presently retails at a significant premium over Rooh Afza in an 800ml bottle (e.g., Rs. 320 vs. Rs. 150-Rs. 180). Would you sell 710ml Double Strength Vimto Syrup if the retail price is lowered substantially (e.g., Rs. 240 for Vimto vs. Rs. 150-Rs. 180 for Rooh Afza), it is nationally advertised, retailer commissions are provided and you are assured of a reliable supply of Vimto?
Q 17A. Why would you not like to sell Double Strength Vimto Syrup even after lower price, consistent supply, strong marketing campaign and higher commissions?"
i) In total, 2789 retail stores owners were interviewed by Foresight. There were four categories of retail stores within the survey sample, namely general stores, self-service stores, kiryana stores and bakeries, although, as I have already indicated, the category of self-service stores included some top end stores such as Naheed in Karachi, which was said to be a typical example of a store which catered for the wealthier elements in Pakistan.ii) 42 of the 2789 retail store sample were Type 1 stores – i.e. those which had previously sold DS at cordial at prices between 310 and 350 rupees. All such stores expected to sell greater volumes of the product at the lower retail price proposed by Gul (220 rupees in year 1 but, since the survey was designed towards the end of year 2,240 rupees in the survey). The median sales volume of DS Cordial at the grey market price was 12 bottles per annum whilst the median expected sales volume at Gul's proposed retail price was 70 bottles per annum.
iii) Of the 2747 stores which had not previously sold DS Cordial (Type 2 stores) 2127 (76% of the sample) were interested in carrying DS Cordial at the lower retail price proposed by Gul. The most common reason advanced as to why they had not sold it before (a reason provided by 80% of the retail stores surveyed) was that the product had not previously been actively marketed to it.
iv) The conclusion reached by Mr Sequeira was that the survey confirmed Gul's contemporaneous survey in November 2011 and its belief that there was a strong untapped demand for DS Cordial in Pakistan.
i) Nichols said that the questions posed in the questionnaire were patently skewed because the supposed advantages of DS Vimto were stressed. I do not consider this to be a valid criticism, save for question 17A. It was necessary for the participants to assess future sales on the basis of the price and commissions which were being offered by Gul, with the assurance of consistent supply and a strong marketing campaign.ii) Criticism was made of the extrapolation of results from such a low number of positive responses in the kiryana stores category and the bakery category (3 and 2 respectively) with the suggestion that one of those estimates of future sales was unreliable. Whilst, as Mr Sequeira accepted, such numbers were less than optimal, statistically, there was a 95% confidence level with a 2.5% margin of error for the General Stores and a 90% confidence level with a 5% margin of error for the remaining categories. There were no grounds for suspicion of the estimated sales of the store in question. Mr Wilkinson's criticism was of the absolute size of the sample as opposed to the sample size relative to the overall population but the "absolute" figures upon which Mr Sequeira relied in the survey were reduced by excluding one kiryana store and one bakery as outliers because of high estimated sales. Mr Sequeira's cautious approach thus had the effect of reducing the numbers.
iii) It was suggested that the extrapolation exercise results in an unreal conclusion because kiryana stores and bakeries are seen as selling more bottles than the self-service stores which include the top-end retail stores. The reason that the self-service stores do not however give rise to the higher figure that might be expected from the top end stores is because the effect of the top-end stores is diluted by the other stores in the category. Bakeries might be expected to have high figures because they operate at the high end of the market, albeit that they are limited in number. The vast majority of the market (96%) is to be found in the general stores and kiryana stores.
iv) The manner in which the survey was conducted means that the results are driven by the responses of store keepers who had sold very few bottles – the median number of actual bottles sold across the whole survey was 12. It was suggested that they would not be well placed to estimate how a change in price might affect their individual sales. In my judgment this too would only have had the effect of reducing the number of sales estimated. The top end stores, with much higher actual sales, which do show significant increases in the estimates of what they expected to sell, would, if used as a basis for extrapolation, give rise to higher figures.
v) There is no logical connection between the results of the survey for Type 1 stores and the assessment of future sales by Type 2 stores. I agree with this point as I have already indicated. The effect of reading across from Type 1 stores to Type 2 stores on a 100% basis would result in Type 2 stores capturing 67% of the Pakistani cordial market within a year, which could not conceivably occur. It was obviously for this reason that Mr Sequeira made the 80% reduction for year 2 and a pro-rata annual reduction from year 5 retrospectively.
vi) In truth, Nichols suggested that the whole projection was based on the groundless assumption that Gul would achieve 13.83% market share by year 6.
vii) On this basis, Nichols invited me to make a finding that Gul would not have made the volume of sales implied by the minimum purchase requirements for concentrates set out in clause 9.3 of the Agreement.
YTD DEC 2011 | YTD DEC 2012 | YTD NOV 2013 | YTD NOV 2013 | YTD NOV 2013 | YTD NOV 2013 | |
Vimto Carbonated |
Vimto Cordial |
Vimto Carbonated | Vimto Cordial |
Vimto Carbonated |
Vimto Cordial |
|
Iran | 294.614 | 104,242 | 31,680 | 66,368 | - | 82,749 |
Iraq | 33,860 | 295,543 | - | 91,008 | 5,350 | 160,326 |
Sales of Vimto Carbonate
Expenses
Discount rate
Lost profits in the first year
Conclusion